In quest to meet user fee goals, FDA’s per­for­mance con­tin­ues down­ward trend

A re­cent up­date to the FDA’s run­ning tal­ly of how it’s meet­ing its user fee-re­lat­ed per­for­mance goals dur­ing the pan­dem­ic shows an agency that is not out of the woods yet.

The lat­est num­bers re­veal that for a sec­ond straight quar­ter in 2021, the FDA has met its user fee goal dates for 93% of orig­i­nal new drug ap­pli­ca­tions, which com­pares with 94% and 98% for the pre­vi­ous two quar­ters in 2020, re­spec­tive­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER